Treatment of HCV infection in patients with cirrhosis
Journal Title: Annals of Hepatology - Year 2010, Vol 9, Issue 0
Abstract
The treatment of patients with cirrhosis has the following purposes: to prevent the complications of the disease; to allow for the regression of cirrhosis; and to prevent reinfection in the graft in patients undergoing liver transplantation. When the sustained viral response is evaluated in patients with cirrhosis, especially in those with decompensated disease, it is noted to be lower than that of patients with chronic hepatitis, and with a higher possibility of complications of the treatment. Based on a review of the literature, we conclude that we should treat patients with compensated cirrhosis, probably also those with portal hypertension, and patients with decompensated cirrhosis only when included on the transplant list, as long as Child B with HCV genotype 2 (possibly 3) and preferably after clinical compensation.
Authors and Affiliations
Angelo Alves de Mattos, Ângelo Zambam de Mattos
The Optimal Transfusion Strategy in Liver Transplantation: The Quest Continues
-
???
Liver overload in Brazilian triathletes after half-ironman competition is related muscle fatigue
Triathlon competition is dependent on the athletes’ ability to perform each discipline at optimal time, without excessive fatigue influencing the next one. Objectives: Determine the effects of a long distance triathlon o...
Mean platelet volume: a useful predictor of ascitic fluid infection in cirrhotic patients?
Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia